Overall Survival with [177Lu]lu-Psma-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (therap): Secondary Outcomes of a Randomised, Open-Label, Phase 2 Trial.Michael S. Hofman,Louise Emmett,Shahneen Sandhu,Amir Iravani,James P. Buteau,Anthony M. Joshua,Jeffrey C. Goh,David A. Pattison,Thean Hsiang Tan,Ian D. Kirkwood,Siobhan Ng,Roslyn J. Francis,Craig Gedye,Natalie K. Rutherford,Andrew Weickhardt,Andrew M. Scott,Sze-Ting Lee,Edmond M. Kwan,Arun A. Azad,Shakher Ramdave,Andrew Redfern,William Macdonald,Alex Guminski,Edward Hsiao,Wei Chua,Peter Lin,Alison Yan Zhang,Martin R. Stockler,Scott G. Williams,Andrew J. Martin,Ian D. DavisLANCET ONCOLOGY（2024）引用 8|浏览53关键词Metastatic Prostate CancerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
